IBS & irritable bowel decisions — 2025

The Board granted an effective date of October 28, 2021, for the award of a 30 percent disability rating for restrictive lung disease with bronchiectasis and chronic granulomatous disease, as well as service connection for irritable bowel syndrome (IBS) with chronic constipation, and an initial 10 percent disability rating for IBS.

The Board remands the claim for an effective date prior to August 10, 2022, for service connection of irritable bowel syndrome (IBS) due to a need for additional evidence and medical opinion.

The Board remands the claims for service connection for a gastrointestinal disorder, claimed as irritable bowel syndrome (IBS), and a left shoulder disorder to correct duty to assist errors.

The Board granted a 30 percent disability rating for the Veteran's service-connected irritable bowel syndrome (IBS) based on the evidence of record.

The Veteran's service-connected PTSD renders her unable to secure or follow a substantially gainful occupation, and she is granted a total disability rating based on individual unemployability (TDIU).

The Board denied service connection for sleep apnea, irritable bowel problems, and a compensable rating for bilateral hearing loss.

The Board denied an increased rating for migraine headaches and GERD, but granted a separate 10 percent rating for irritable bowel syndrome.

The Board remands the claim for a new medical opinion to address whether the Veteran's irritable bowel syndrome is related to toxic exposure risk activities during his active military service, including contaminated water exposure at Camp Lejeune.

The Board denied a higher disability rating for IBS with GERD in excess of 30 percent and granted a separate 10 percent rating for GERD on and after May 19, 2024.

The Board granted a 10 percent rating for irritable bowel syndrome (IBS) based on frequent episodes of bowel disturbance with abdominal distress.

The Board dismissed all claims for service connection and an increased rating due to the lack of new and relevant evidence, except for sinusitis which was not readjudicated.

The Board granted an effective date of August 29, 2007, for the award of service connection for PTSD and denied service connection for bilateral hearing loss and an increased rating for irritable bowel syndrome.

The Board denied service connection for vitamin D deficiency and denied higher ratings for irritable bowel syndrome, palpitations/sinus tachycardia, and hyperthyroidism. However, a 20 percent rating was granted from May 19, 2024, to August 28, 2024, for IBS, and a 30 percent rating was granted from September 5, 2023, for palpitations/sinus tachycardia.

The Board granted an earlier effective date of April 21, 2022 for the grant of service connection for both irritable bowel syndrome and allergic rhinitis.

The Board denied the veteran's claim for service connection for an intestinal disorder, to include irritable bowel syndrome (IBS), as there was no evidence of a current disability.

The Board granted service connection for hyperthyroidism and denied service connection for glaucoma, sleep apnea, lung condition (including COPD and asthma), GERD, breast cancer, IBS, blood clots, and heart condition. The claims for bilateral hearing loss and tinnitus were remanded.

The Board granted service connection for a low back disability, left knee disability, right ankle disability, chronic sinusitis, and irritable bowel syndrome (IBS) as they were found to have onset in service.

The appeal of the proposed rating reductions for irritable bowel syndrome and PTSD with MDD was dismissed due to a claims processing error, as these were merely proposals and not final decisions.

The Board denied service connection for mid/lower back, right shoulder, right and left knee, bilateral flatfoot, GERD, irritable bowel syndrome (IBS)/irritable colon, and bilateral hearing loss disorders. The claim for CHF was remanded for further development.

The Board granted an initial rating of 10 percent for irritable bowel syndrome (IBS), a total disability rating based on individual unemployability (TDIU) for the period prior to March 8, 2023, and special monthly compensation (SMC) under the provisions of 38 USC § 1114(s)(1) for the period beginning August 10, 2022.